With with GLP-1 drugs, gastrointestinal issues, such as nausea, vomiting, constipation, and gastroesophageal reflux disease, ...
The Food and Drug Administration’s approval of Ozempic in 2021 for weight loss treatment ushered in a new era for the class ...
In this Saturday edition of BI Today, we're talking about the end of a GLP-1 shortage, and Hollywood's awards season.